Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Curasept Prevent
- Development stage
- Unknown
- Lead developer
- Curasept
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Topical, Oral
01
Overview
Curasept Prevent is a specialized oral hygiene product line developed by Curasept S.p.a. for the prevention and management of periodontal and peri-implant diseases. The formulation is a combination of ozonated olive oil, postbiotics, and probiotics. Ozonated olive oil provides antimicrobial activity by releasing oxygen, which targets anaerobic pathogens, while postbiotics and probiotics work to restore oral eubiosis and strengthen the local immune response. The product line is currently being evaluated in clinical trials, such as those led by Massimo Corsalini, for its efficacy in patients with Stage I and II periodontitis, particularly those with systemic risk factors like smoking, obesity, or diabetes.
- Brand names
- Curasept Prevent
- Other names
- Curasept Prevent ToothpasteCurasept Prevent MouthwashCurasept Prevent ProbioticCurasept Prevent Gel
Beyond the preview
Go deeper on Curasept Prevent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Curasept Prevent.